glp-1 agonist common side effects What are experts learning about the long-term of medications? As more people stay on these medications for longer periods of time, researchers are paying closer attention to potential effects Frontiers | Evaluation of GLP-1
Description
N Engl J Med 2022;387(3):205216

These discoveries were later confirmed using a similar glucagon/long-acting GLP-1 dual receptor agonist

C.LorencV.PerissetS.GalloJ

Combining these medications with GIPR antagonist medications, glucagon receptor agonists, GLP-2R agonists, or agonists of amylin receptors might enhance their benefits

FDA Investigating Reports of Possible Increased Risk of Pancreatitis and Pre-cancerous Findings of the Pancreas From Incretin Mimetic Drugs for Type 2 Diabetes
The success of both compounds, using different combinations of the same three receptor targets, has validated the multi-agonist approach and opened the door for even more combinations
